Author

R. Ishida

University of British Columbia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Bioengineering· 1 Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:cell type annotation· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Assay:behavioral assay· 1 Research Focus:development & morphogenesis· 1 Assay:electrophysiology· 1

Frequent Co-Authors

H. Kagechika· 2 shared N. Kurebayashi· 2 shared S. Mori· 2 shared T. Murayama· 2 shared T. Sakurai· 2 shared A. C. Wilkinson· 1 shared A. Copp· 1 shared A. Kimura· 1 shared

Activity by Year

2019-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

H. Kagechika

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Prenatal exposure to dietary levels of glyphosate disrupts metabolic, immune, and behavioral markers across generations in mice.

Jacqueline A. Barnett, Jessica K. Josephson, E. Yuzbashian, Natasha Haskey, Miranda M. Hart, Kiran K. Soma, A. Verdugo, C. J. McComb, Maya L. Bandy, Sanjoy Ghosh, Clara A. Letef, A. Copp, R. Ishida, Julien Gibon, Jiayu Ye, , Deanna Lynn Gibson

The Science of The Total Environment · Sep 26, 2025Peer-reviewedPharmacology & Toxicology

Screening for novel RyR2 inhibitors by ER Ca2+ monitoring

M. Takenaka, M. Kodama, T. Murayama, M. Ishigami-Yuasa, S. Mori, R. Ishida, J. Suzuki, K. Kanemaru, M. Sugihara, M. Iino, A. Miura, H. Nishio, S. Morimoto, H. Kagechika, T. Sakurai, N. Kurebayashi

This study identifies three RyR2 inhibitors using an ER Ca2+ monitoring assay, showing they suppress arrhythmogenic Ca2+ waves without affecting normal Ca2+ transients.

bioRxiv · Aug 21, 2023 · PreprintPharmacology & Toxicology

Reconstituted depolarization-induced Ca2+ release platform for skeletal muscle disease mutation validation and drug discovery

T. Murayama, N. Kurebayashi, T. Numaga-Tomita, T. Kobayashi, S. Okazaki, K. Yamashiro, T. Nakada, S. Mori, R. Ishida, H. Kagechika, M. Yamada, T. Sakurai

The paper establishes a reconstituted DICR platform in HEK293 cells to validate skeletal muscle disease mutations and test drug candidates.

bioRxiv · Jun 29, 2022Physiology

A Single Cell Cloning Platform for Gene Edited Functional Murine Hematopoietic Stem Cells

H. J. Becker, R. Ishida, A. C. Wilkinson, T. Kimura, M. S. J. Lee, C. Coban, Y. Ota, A. Tojo, D. Kent, S. Yamazaki

The paper presents a method to expand and profile genetically edited murine hematopoietic stem cells at clonal density to reduce genetic heterogeneity before transplantation.

bioRxiv · Mar 23, 2022 · PreprintCell Biology

Elasticity and Topography-Controlled Collagen Hydrogels Mimicking Native Cellular Milieus

T. G. Oyama, K. Oyama, A. Kimura, F. Yoshida, R. Ishida, M. Yamazaki, H. Miyoshi, M. Taguchi

This study develops collagen hydrogels that mimic native ECM by combining elasticity, topography, and composition, showing topography overrides elasticity in controlling cell morphology.

bioRxiv · Jul 18, 2019Bioengineering